ISSN: 2155-9937
Marc Bickle, PhD
Head, Max Planck Institute of Molecular Cell Biology and Genetics
Germany
Dr. Marc Bickle obtained his PhD title at the Biozentrum of the University of Basel Switzerland in the laboratory of Prof Michael N Hall studying the mode of action of the immunosuppressive drug Rapamycin using yeast as a model system After receiving his degree he went to the Laboratory of Molecular Biology in Cambridge UK to work in the laboratory of Prof Jonathan Hodgkin to study the molecular mechanism underlying behavior using C elegans as a model organism He then left England for Lyon France where he participated in the creation of a Biotech company Aptanomics SA He headed the yeast and molecular biology groups and developed several yeast 2 hybrid screening methods to obtain peptide aptamers and small chemical compounds targeting proteinprotein interactions He then went to Max Planck Institute of Molecular Cell Biology and Genetics MPICBG in Dresden Germany where he headed a group developing live cell High Content Screening methodologies.
Molecular Cell Biology.